- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
DBN1 Monoclonal Antibody ABDC-4 / Drebrin 1 Monoclonal Antibody recognizes drebrin, an actin-binding protein encoded by the DBN1 gene that participates in cytoskeletal organization and neuronal development. Drebrin is particularly abundant in the nervous system, where it contributes to the structural organization of dendritic spines and the regulation of synaptic connections. Through interactions with filamentous actin (F-actin), drebrin influences cytoskeletal dynamics, cell morphology, and the formation of specialized cellular structures.
Drebrin binds along actin filaments and alters their interactions with other actin-associated proteins. Its association with F-actin can influence filament bundling, stability, and remodeling, helping regulate the organization of actin-rich cellular compartments. In neurons, drebrin is enriched in dendritic spines, small protrusions that receive most excitatory synaptic inputs. The actin cytoskeleton within these structures undergoes continuous remodeling during synapse formation and activity-dependent changes in synaptic strength. Drebrin contributes to this process by supporting spine maturation and maintaining the structural organization required for synaptic signaling.
Alternative splicing produces major drebrin isoforms commonly designated drebrin E and drebrin A. Drebrin E is expressed more broadly and is associated with developing neurons and various non-neuronal cells, while drebrin A becomes prominent during neuronal maturation. This developmental transition accompanies changes in dendritic spine morphology and synaptic organization. Drebrin also participates in cell migration, epithelial junction organization, and other processes involving actin remodeling outside the nervous system. Its interactions with additional cytoskeletal regulators help coordinate changes in cell shape and local actin architecture.
Altered drebrin expression and localization have been investigated in neurodegenerative disorders, particularly Alzheimer's disease, where reduced drebrin abundance in vulnerable brain regions has been associated with synaptic deterioration. Experimental studies have also linked drebrin dysregulation to abnormalities in dendritic spine formation, neuronal connectivity, and cognitive function. These findings have made DBN1 an important target in research on synaptic maintenance and neurodegeneration. NSJ Bioreagents offers this DBN1 Monoclonal Antibody for investigating actin cytoskeletal organization, dendritic spine biology, and mechanisms underlying synaptic structural plasticity.
This antibody can be compared with our Drebrin Antibody / DBN1 Neuronal Actin-Binding Protein Antibody (clone DBN1/2880) for consistent detection of DBN1 across neuronal structure and cytoskeletal studies.
Optimal dilution of the DBN1 Monoclonal Antibody ABDC-4 / Drebrin 1 Monoclonal Antibody should be determined by the researcher.
A synthesized peptide derived from human Drebrin was used as the immunogen for the DBN1 Monoclonal Antibody ABDC-4.
The DBN1 Monoclonal Antibody ABDC-4 can be stored at -20oC.
Drebrin synaptic antibody, DBN1 spine marker antibody, Drebrin dendritic spine antibody, DBN1 neuronal plasticity antibody, Developmentally regulated brain protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.